A detailed history of Ingalls & Snyder LLC transactions in Metlife Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 3,575 shares of MET stock, worth $298,047. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,575
Previous 3,175 12.6%
Holding current value
$298,047
Previous $223,000 32.29%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.96 - $82.48 $27,183 - $32,992
400 Added 12.6%
3,575 $295,000
Q1 2024

May 13, 2024

SELL
$65.35 - $74.11 $9,802 - $11,116
-150 Reduced 4.51%
3,175 $235,000
Q3 2023

Nov 02, 2023

BUY
$56.71 - $66.36 $188,560 - $220,647
3,325 New
3,325 $209,000
Q4 2022

Jan 31, 2023

BUY
$62.62 - $76.95 $2,191 - $2,693
35 Added 1.05%
3,360 $243,000
Q3 2021

Oct 27, 2021

BUY
$55.86 - $63.61 $185,734 - $211,503
3,325 New
3,325 $205,000

Others Institutions Holding MET

About METLIFE INC


  • Ticker MET
  • Exchange NYSE
  • Sector Financial Services
  • Industry Insurance—Life
  • Shares Outstandng 797,614,016
  • Market Cap $66.5B
  • Description
  • MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...
More about MET
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.